Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26,336Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Jakavi

PharmaCompass

01

Brand Name : Jakavi

Ruxolitinib

arrow
GRx+Biosims
Not Confirmed

02

Brand Name : Jakavi

Ruxolitinib

arrow
GRx+Biosims
Not Confirmed

03

Brand Name : Jakavi

Ruxolitinib

arrow
GRx+Biosims
Not Confirmed

Brand Name : Jakavi

arrow
GRx+Biosims
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 1,561

2021 Revenue in Millions : 1,595

Growth (%) : -2

blank

04

Brand Name : Jakavi

Ruxolitinib

arrow
GRx+Biosims
Not Confirmed

05

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
GRx+Biosims
Not Confirmed

06

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
GRx+Biosims
Not Confirmed

07

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
GRx+Biosims
Not Confirmed

08

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
GRx+Biosims
Not Confirmed

09

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
GRx+Biosims
Not Confirmed

10

Brand Name : Jakavi

Ruxolitinib

arrow
GRx+Biosims
Not Confirmed